CADTH | Evidence Driven
CADTH | Evidence Driven

Switching From Reference to Biosimilar Insulin Aspart for Patients With Diabetes Mellitus (Type 1 or Type 2)

Details

Files
Project Status:
Completed
Project Line:
Reference List
Project Sub Line:
Summary of Abstracts
Project Number:
RB1600-000

Question

  1. What is the clinical effectiveness of switching from reference to biosimilar insulin aspart in adult or pediatric patients with diabetes mellitus (Type 1 or Type 2)?

Key Message

Two randomized controlled trials were identified regarding the clinical effectiveness of switching from reference to biosimilar insulin aspart in adult or pediatric patients with diabetes mellitus (Type 1 or Type 2).

Files

Switching From Reference to Biosimilar Insulin Aspart for Patients With Diabete… View PDF

Related Content

Last Updated : November 17, 2021